financetom
Business
financetom
/
Business
/
France's CFDT union may take strike action over Exxon job cuts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
France's CFDT union may take strike action over Exxon job cuts
Sep 16, 2024 12:20 PM

PARIS, Sept 16 (Reuters) - France's CFDT trade union

said on Monday that it could join an ongoing strike by the CGT

union at ExxonMobil's ( XOM ) Port Jerome refinery as talks with

the company near a deadline.

So far, the strike action has been limited to chemical

workers after Exxon said it would shut down its steam cracker

and close chemical production at the site this year.

Exxon has two refineries in France that account for about

30% of the country's capacity. A spokesperson said the strikes

have not impacted its refining, despite a blockade in late June.

The closures at the facility will mean 608 employees losing

their jobs from 2025, the Exxon spokesperson told Reuters.

The end of information and consultation period for the

workforce support package is Sept. 20, so Exxon and the unions

need to reach an agreement by the end of the week, they added.

CFDT, one of France's largest unions, said in a statement it

was worried that working conditions would be significantly

degraded by the proposed changes.

"The CFDT currently does not rule out any action, including

legal action, to defend the interests of all employees, but

prefers to return to the negotiating table," it said.

The CFDT took part in strikes last year at French refineries

over President Emmanuel Macron's pension reforms, which saw

disruptions to fuel supplies across the country.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Lilly to Appeal Against UK Regulator's Recommendation Not to Reimburse Cost of Alzheimer's Drug
Update: Lilly to Appeal Against UK Regulator's Recommendation Not to Reimburse Cost of Alzheimer's Drug
Jun 20, 2025
09:26 AM EDT, 06/20/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Thursday it was planning to appeal against the UK's National Institute for Health and Care Excellence's, or NICE's, decision not to reimburse the cost of Alzheimer's drug Kisunla under the National Health Service. The drugmaker said the regulator's decision is unreasonable based on the evidence submitted by...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Actuate Therapeutics Identifies Biomarkers in Treatment of Metastatic Pancreatic Cancer in Phase 2 Trial
Actuate Therapeutics Identifies Biomarkers in Treatment of Metastatic Pancreatic Cancer in Phase 2 Trial
Jun 20, 2025
09:17 AM EDT, 06/20/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Friday that its phase 2 trial of elraglusib in combination with gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer demonstrated the use of machine learning and statistical models to predict overall survival based on pre-dose plasma biomarkers. The analysis identified seven biomarkers as uniquely significant predictors of favorable survival...
BlackBerry's Valuation to Remain Discounted on 'Conservative' Guidance, RBC Says
BlackBerry's Valuation to Remain Discounted on 'Conservative' Guidance, RBC Says
Jun 20, 2025
09:16 AM EDT, 06/20/2025 (MT Newswires) -- BlackBerry's (BB) conservative guidance has set the bar low for fiscal Q1 earnings and the company's valuation is likely to remain discounted, pending improved visibility to sustained growth, RBC Capital Markets said in a Friday note. The company's fiscal Q1 results could exceed RBC's and consensus estimates, as the macro environment has been...
Copyright 2023-2026 - www.financetom.com All Rights Reserved